Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / Events / Events / Past Events

Past Events

Events which have already happened.
From nano to meso-scale organization of DC-SIGN: a relationship between large scale ordering and dynamics Feb 27, 2013 from 01:30 PM to 02:00 PM 124 Taylor Hall, by Susan Lucas
Maria Garcia-Parajo, Institute of Photonic Sciences, Barcelona, Spain
Natural and Engineered Protein Cages: Structure, Function, and Frameworks for Synthetic Biology Feb 27, 2013 from 11:00 AM to 12:00 PM 1131 Bioinformatics Building, by Susan Lucas
Todd Yeates, Professor, University of California at Los Angeles
Structural Basis for the Regulation of GIRK Channel Gating by Soidium, PIP2 and G Proteins Feb 26, 2013 from 04:00 PM to 05:00 PM 1131 Bioinformatics, by Elneter Stroud Mack (mstroud)
Matt Whorton, PhD, Faculty Candidate
Clinical Trial Investigator Series: Finding Funding Through Novartis Feb 26, 2013 from 03:00 PM to 04:30 PM 219 Brinkhous-Bullitt Building, by Susan Lucas
A Novartis Rep. will be presenting on how clinical trial investigators can gain entrée into Novartis, a pharmaceutical company.
Genetic and Proteomic Identification of E3 Ubiquitin Ligase Substrates Feb 26, 2013 from 12:30 PM to 01:30 PM 00-002 Joseph S. Pagano Conference Room, Lineberger, by Susan Lucas
Michael J. Emanuele, PhD, Assistant Professor, Department of Pharmacology, Lineberger Comprehensive Cancer Center
Designing Chemically Robust Metal Oxides for Visible-Light Photocatalysis: toward Solar Z-Scheme Water Splitting Feb 26, 2013 from 11:00 AM to 12:00 PM 125 Chapman, by Susan Lucas
Bart Bartlett, Assistant Professor of Chemistry, University of Michigan
Tissue compartmentalization of immune responses in infection and homeostasis Feb 26, 2013 from 09:30 AM to 10:30 AM 1131 Bioinformatics Building, by Susan Lucas
Donna L. Farber, Ph.D., Columbia University
The Role of T-Lymphocytes in Salt-Sensitive Hypertension and Renal Damage Feb 25, 2013 from 12:00 PM to 01:00 PM G202 MBRB, by Susan Lucas
David L. Mattson, PhD, Medical College of Wisconsin
Testing for Performance Enhancing Drugs Feb 25, 2013 from 12:30 PM to 01:00 PM 125 Chapman, by Susan Lucas
Thomas Eisenhart, UNC-CH
Ion Mobility Spectroscopy Feb 25, 2013 from 12:00 PM to 12:30 PM 125 Chapman, by Susan Lucas
Leah Heist, UNC-CH
Global Cervical Cancer Prevention: From Research to Implementation Feb 25, 2013 from 09:00 AM to 10:00 AM 0001 BCBS Auditorium, Michael Hooker Research Center, by Susan Lucas
Jennifer Smith, PhD, Research Associate Professor, Department of Epidemiology, University of North Carolina at Chapel Hill
New Approaches to C–F and C–C Bond Formation by Transition Metal Catalysis Feb 22, 2013 from 12:00 PM to 12:30 PM 125 Chapman, by Susan Lucas
Abigail Doyle, Assistant Professor of Chemistry, Princeton University
Cluster Crystals and Other Surprises in Flatland Feb 21, 2013 from 04:00 PM to 04:30 PM 125 Chapman, by Susan Lucas
Zvonimir Dogic, Associate Professor of Physics, Brandeis University
Patient-Centered Outcomes and Comparative Effectiveness Research: It’s History, Current State, and Opportunities Feb 21, 2013 from 03:00 PM to 04:00 PM 00-002 Joseph S. Pagano Conference Room, Lineberger, by Susan Lucas
Jean R. Slutsky, M.S.P.H., Director, Center for Outcomes and Evidence, Agency for Healthcare Research and Quality
Tobacco Cessation & PCMH: Advances in Evidence-based Treatment Webinar Feb 20, 2013 from 05:00 PM to 06:00 PM Brinkhous-Bullitt Building, Room 219, by Mary Ruth
Presenters: Adam Goldstein, MD and Carol Ripley-Moffitt, MDiv, CTTS
Metabolomics in exploratory toxicology: Consequences of treatment with the candidate chemopreventive agent pentamethylchromanol (PMCol) Feb 20, 2013 from 02:00 PM to 03:00 PM G-605 Koury , by Susan Lucas
Jonathan McDunn, PhD., Associate Director, Diagnostics Research and Development at Metabolomic Inc. and Adjunct Associate Professor of Biomedical Engineering, UNC-Chapel Hill
Metabolomics in exploratory toxicology: Consequences of treatment with the candidate chemopreventive agent pentamethylchromanol (PMCol) Feb 20, 2013 from 02:00 PM to 03:00 PM G605 Koury (1st floor new Dental School Building), by Susan Lucas
Jonathan McDunn, Ph.D., Associate Director, Diagnostics Research and Development at Metabolomic Inc. & Adjunct Associate Professor, UNC Department of Biomedical Engineering
Combining Radiation with Molecular Targeting Agents in Oncology Feb 19, 2013 from 04:00 PM to 05:00 PM 00-002 Joseph S. Pagano Conference Room, Lineberger, by Susan Lucas
Paul M. Harari, MD, FASTRO, Jack Fowler Professor and Chairman, Department of Human Oncology, University of Wisconsin School of Medicine and Public Health
X-Inactivation as a Paradigm of RNA-Mediated Gene Silencing Feb 19, 2013 from 04:00 PM to 05:00 PM 1131 Bioinformatics, by Elneter Stroud Mack (mstroud)
Joseph M. Calabrese, PhD, Faculty Candidate
Addressing Disparities Using Principles of Community Based Participatory Research:The NC BEAUTY and Barbershop Story Feb 19, 2013 from 12:00 PM to 01:00 PM 104 Carrington Hall , by Susan Lucas
Laura Linnan, Sc.D., Professor, Department of Health Behavior and Health Education School of Public Health
« April 2014 »
month-4
Mo Tu We Th Fr Sa Su
31 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 1 2 3 4